News

EXPLORE THE LATEST NEWS AND PUBLICATIONS FROM 3T BIOSCIENCES

January 9, 2023

Boehringer Ingelheim and 3T Biosciences Join Forces to Develop Next-Generation Cancer Immunotherapies

October 25, 2022

3T Biosciences Announces Appointment of John Leonard, M.D. to its Board of Directors

August 25, 2022

3T Biosciences Debuts with $40 Million Series A Financing

Spiral cells graphic